26. Aug. 2026•1 Min. Lesezeit
FDA Approves Multiple Submissions for APRESAZIDE (ANDA 084735)
The FDA lists APRESAZIDE oral capsules (hydralazine HCl 25 mg / hydrochlorothiazide 25 mg) as discontinued, with a series of approved original and supplemental submissions from 1976 to 1998.